As part of our coverage of the 2015 American Society of Hematology annual meeting, myeloma expert Dr. Paul Richardson joined Patient Power to discuss this years approvals for the treatment of multiple myeloma, which includes seven total agents. Dr. Richardson reviews each of the treatments and shares how these new therapies work and how they impact multiple myeloma survival.
Get email alerts | http://www.patientpower.info/alerts
Subscribe on YouTube | http://www.youtube.com/patientpower
Like on Facebook | http://www.fb.com/patientpower.info
Follow on Twitter | http://www.twitter.com/patientpower
Follow on Google+ | http://www.google.com/+patientpowerinfo